Interesting update, things don't look great but that's no...

Interesting update, things don't look great but that's no surprise. I thought the comments from the new CEO were good and about as critical of past management as you could really put on paper. A lot of talk about reducing spend and streamlining the business, not a lot of talk about nasal spray.

No mention of AZ as a partner outside of the about SPL blurb. It's a pity that the ASX doesn't make companies substantiate things they put in the activities report - "Starpharma’s partnered research programs, including those with MSD and Genentech, continued to progress." Wonder if they will take questions at the proposed webinar.